RFI JPEO CBRND/JPL EB 2024 CBD S&T Conference 1:1 Sessions
Closed Special Notice Posted
- Solicitation number
- W911SR-EB-CBD-STConference
- Agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Place of performance
- Fort Lauderdale, Florida 33316, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Special Notice is issued by the Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground on behalf of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND). It is seeking to meet with companies that have capabilities or technologies in the areas of Chemical, Biological, Radiological and Nuclear (CBRN) defense, specifically related to developmental or FDA-approved prophylactics and therapeutics that have completed Phase 1 clinical trials and shown efficacy for a CB indication, as well as technologies that speed up the development and/or production of prophylactics, therapeutics, and diagnostics.
The purpose of this Special Notice is to invite companies with relevant CBRN defense capabilities to sign up for 1-on-1 sessions at the 2024 Chemical and Biological Defense Science & Technology (CBD S&T) Conference, scheduled for December 2-5, 2024 in Fort Lauderdale, Florida. The deadline to sign up for these 1-on-1 sessions is November 8, 2024. The JPEO CBRND is the Defense Department's premier program management office for investment and development of platform technologies and programs to provide medical solutions during crisis and improve preparedness for future threats.
Notice text
CBD RFI
JPEO-CBRND JPL Enabling Biotechnology
Do you have a capability that enables Chemical, Biological, Radiological and Nuclear Defense (CBRND)? Will you be attending the Chemical and Biological Defense Science & Technology (CBD S&T) Conference 2-5 December 2024?
JPL CBRN Enabling Biotechnology, within the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND)serves as the Defense Department’s (DoD) premier program management office for investment and development of platform technologies and programs to provide medical solutions during crisis and improve preparedness for future threats.
If you have a capability or technology in the following CBD relevant areas:
Developmental and/or FDA approved Prophylactics and Therapeutics and that
- Have completed Phase 1 Clinical trial
- Have shown efficacy for a CB indication,
- Technologies that speed-up the development and/or production of
- Prophylactics
- Therapeutics
- Diagnostics
We’d like to meet with you.
Please visit the JETT registration page to sign up for a time slot to meet with us at https://jacks.jpeocbrnd.army.mil/JETT
Looking forward to seeing you in Ft. Lauderdale at the 2024 CBD S&T Conference! Link to register: https://www.dtra.mil/About/Mission/Research-and-Development/#:~:text=The%20Chemical%20and%20Biological%20Defense%20Science%20&%20Technology
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity